Evofem Biosciences, Inc. (EVFM): auditor change — Evofem Biosciences dismisses Deloitte, appoints BPM as auditor; reduces stockholder quorum to one-third

the Audit Committee recommended, and the Board approved the dismissal of Deloitte & Touche LLP ("Deloitte"), as the Company's independent registered public accounting firm, on July 11, 2023.

On July 11, 2023, the Company appointed BPM LLP ("BPM") as the Company's new independent registered public accounting firm effective as of July 11, 2023.

On July 11, 2023, the board of directors the (“Board”) of Evofem Biosciences, Inc. (the “Company”), adopted and approved an amendment and restatement of the Company’s Amended and Restated Bylaws (the “Second Amended and Restated Bylaws”) in order to change, among other things: ● Section 2, removing requirement for Board Consent to reschedule annual meeting ● Section 3, so the proportion of shares present required to constitute a quorum at a meeting of stockholders, from a majority to one-third of the outstanding shares of stock entitled to vote, as permitted under § 216 of the Delaware General Corporation Law.